Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance Temozolomide in NSCLC
NCT00632203Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Mar 2008
- Primary completion
- Jan 2011
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of temozolomide in non-small cell lung cancer (NSCLC), sponsored by Merck & Co.. Started Mar 2008; status: terminated.
02
Drugs
temozolomide
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00632203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00632203.